Loading...

Buy Full Version
"Chagas Disease Treatment Market"

Let us help you !

Invalid Email.

Please Select Country.

Invalid contact no.

Special Symbols Not Allowed.

Invalid Security Code.

Thank You For Your Interest.

We've Successfully Got Your Message,

Our Executive will get back to you Shortly.

Chagas Disease Treatment Market by Treatment Type (Antiparasitic Treatment, and Symptomatic Treatment), Drug Type (Benznidazole, and Nifurtimox) and Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies): Global Opportunity Analysis and Industry Forecast, 2019–2026

LI_195476
Pages: NA
Dec 2019 | 151 Views
 
Author(s) : NA
Tables: NA
Charts: NA
 

Chagas disease or American trypanosomiasis is a tropical parasitic disease caused by kinetoplastid protozoan parasite called Trypanosoma cruzi, which transmits the infectious disease to humans and animals. The Chagas disease is transmitted by insect vectors known as kissing bugs or Triatominae. It can be passed from the mother to fetus during pregnancy, by blood transfusions, and sometimes through organ transplantation. Early stage symptoms of Chagas disease include fever, headache, and local swelling at the site of the bite and swollen lymph nodes. First visible indication in around 50% people who are bitten by the triatominae bug is purplish inflammation of an eyelid or skin lesion. Moreover, other indications include muscle pain, difficulty in breathing, enlarged lymph glands, swelling, headache, pallor, and abdominal or chest pain. Chagas disease shows two phases of symptoms such as acute phase and chronic phase. In acute phase symptoms are either absent, mild or non-specific. In chronic phase patients suffers from neurological and digestive problem such as enlargement of colon or esophagus. Chagas disease is one of the rare infectious diseases observed across the world. According to the World Health Organization report, as of February 2018, there were around 6—7 million people infected with Chagas disease across the world. The patients with Chagas disease are commonly treated with antiparasitic drugs. Treatment for Chagas disease is targeted on killing the parasite and managing signs and symptoms. During the acute phase of Chagas disease, treatment can be done with benznidazole and nifurtimox medications. Furthermore, a  cure is unavailable once it progresses to the chronic phase. However, medications can be offered to people aged below 50, which can help slower the progression of the disease. 

Increase in R&D activities for development of novel Chagas disease treatment and approval for new products, rise in the prevalence of Chagas disease due to unhygienic conditions, and increase in the Chagas disease population are the factors that drive the growth of the Chagas disease treatment market during the forecast period. Key players are also expected to enter this market by development of vaccines for Chagas disease. However, supply chain issues with Chagas disease drugs, lack of awareness relating to the Chagas disease treatment, and limited number of approved products in the current market are estimated to restrain the growth of the Chagas disease treatment market during the forecast period.

The Chagas disease treatment market is segmented based on treatment type, drug type, distribution channel, and region. Based on treatment type, the market is bifurcated into antiparasitic treatment, and symptomatic treatment. Based on drug type, the market is segmented into benznidazole, and nifurtimox. Based on distribution channel, the market is divided into hospital pharmacies, online pharmacies, and retail pharmacies. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major players operating in the Chagas disease treatment market include Bayer AG (Germany), AstraZeneca (U.K), Daiichi Sankyo Company Ltd (Japan), Eisai Co Ltd (Japan), GlaxoSmithKline Plc. (U.K), KaloBios Pharmaceuticals, Inc. (U.S.), Kancera AB (Sweden), Novartis AG (Switzerland), Laboratorio Elea S.A.C.I.F. y A (Argentina), Oblita Therapeutics BVBA (Belgium), Sanofi Aventis (France), and Grupo Praxis Pharmaceutical SA (Spain).

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides a detailed quantitative analysis of the current market trends and market forecast estimations from 2019 to 2026, which assists to identify the prevailing Chagas disease treatment market opportunities. 
  • An in-depth market analysis includes analysis of various regions and is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the global market is provided.
  • The projections in this report are made by analyzing the current market trends and future market potential from 2019 to 2026 in terms of value.
  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
  • Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which helps understand competitive outlook of the global Chagas disease treatment market.  

KEY MARKET SEGMENTS

By Treatment Type

  • Antiparasitic Treatment
  • Symptomatic Treatment

By Drug Type

  • Benznidazole
  • Nifurtimox

By Distribution Channel

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Australia
    • Japan
    • India
    • China
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

   

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry

REQUEST TOC/SAMPLE

Request Customization

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Chagas Disease Treatment Market

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,370  $4,833
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995  $8,096
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 
image image image image image image image image image image image image image image image image image image image
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 
REQUEST TOC/SAMPLE